NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Infosys Share Price Remains Under Pressure Ahead of Q4 Results Announcement

Infosys share price was trading over 1 percent lower in Thursday's trading session, as investors await the company's March quarter results announcement. The IT stock opened at ₹1,249 apiece today, a decline from the previous close of ₹1,268.60 on Wednesday. This follows a weak market sentiment, poor discretionary demand, and fear of AI-led disruption, which has led to a 4.58% decline in the stock's value over the past week and a 23% year-to-date (YTD) decline.

Three-Year and Five-Year Performance

Over the past three years, Infosys shares have given over 3% returns, however, the stock has fallen 5.62% in the past five years. Despite this, the company continues to have strong long-term fundamentals, supported by digital transformation demand and a healthy deal pipeline.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Brokerage Firm Predictions

Brokerage firm Kotak Institutional Equities (KIE) expects Infosys to report a 1% sequential (QoQ) decline in revenue, largely due to fewer billing days and typical seasonal softness. The firm also projects revenue growth guidance of 3–5%, including the contribution from the Versent acquisition, and 2.25–4.25% on an organic basis.

Brokerage FirmRevenue Growth Guidance (QoQ)Revenue Growth Guidance (YoY)
Kotak Institutional Equities (KIE)-1%3-5% (including Versent acquisition), 2.25-4.25% (organic)

Research Analyst Predictions

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Seema Srivastava, Senior Research Analyst at SMC Global Securities, believes that Infosys' Q4FY26 performance is likely to remain largely steady with only modest sequential revenue growth. Srivastava noted that sequential margin improvement may provide some support, driven by cost optimisation efforts, better utilisation, and operational efficiencies.

Technical Outlook

Commenting on the technical outlook, Anshul Jain, Head of Research at Lakshmishree, said that the IT stock has corrected sharply by 29% in just 31 sessions, followed by a rebound toward the 50-day EMA that failed to sustain, indicating weak follow-through and lack of relative strength. Jain highlighted that the recent breakdown below the rising trendline at 1275 reflects continued pressure, but the stock now appears oversold after an extended decline.

Technical IndicatorValue
Price (Thursday's close)₹1,249
Previous close₹1,268.60
50-day EMA(failed to sustain)

The key overhang remains the likely conservative FY27 guidance, reflecting ongoing global uncertainties, trade-related concerns, and cautious client spending behaviour. This may restrict any meaningful re-rating in the near term, according to Srivastava.

Investor Takeaway

Investors should be cautious about buying Infosys shares ahead of its Q4 earnings release due to weak market sentiments and poor discretionary demand.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.